Oxfendazole clinical trials
How each study uses oxfendazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the oxfendazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 8
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Johns Hopkins Bloomberg School of Public Health (2) · Swiss Tropical & Public Health Institute (1) · Universidad Peruana Cayetano Heredia (1) · Asociacion Benefica Prisma (1) · Oxfendazole Development Group (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test oxfendazole.
- Feb 2027A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in AdultsPhase 2 · Asociacion Benefica Prisma
Studies
Open first, then newest update. How each study uses oxfendazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in AdultsRecruitingPhase 2Asociacion Benefica PrismaNCT04713787Written as Oxfendazole
- One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic FascioliasisNot yet recruitingPhase 2Universidad Peruana Cayetano HerediaNCT06367361Written as Oxfendazole
- Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in AdultsWithdrawnPhase 2Oxfendazole Development GroupNCT03435718Written as Oxfendazole
- PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole TabletsCompletedPhase 1Swiss Tropical & Public Health InstituteNCT04920292Written as Oxfendazole
- Phase I Trial Evaluating the Safety and Pharmacokinetics of OxfendazoleCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02234570Written as Oxfendazole
- Multiple Ascending Dose Study of Oxfendazole in Healthy Adult VolunteersCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03035760Written as Oxfendazole
- Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in AdultsWithdrawnPhase 2Johns Hopkins Bloomberg School of Public HealthNCT02636803Written as oxfendazole
- Single Ascending Dose Safety Study of OxfendazoleWithdrawnPhase 1Johns Hopkins Bloomberg School of Public HealthNCT01584362Written as oxfendazole
Codes
What other systems call oxfendazole · ClinicalTrials.gg INT002514
- MeSH (NLM) C011030oxfendazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) OMP2H17F9EOXFENDAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 32634Confirmed FDA, Wikidata
- Wikidata Q7115199oxfendazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75229OxfendazoleOne source FDA
- DrugBank DB11446One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C011030 | oxfendazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | OMP2H17F9E | OXFENDAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 32634 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7115199 | oxfendazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75229 | Oxfendazole | One source FDA |
| DrugBank | DB11446 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.